Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TXNRD1 | Q16881 | 2/20 | 0.55 |
| ▸ | TXNRD3 | Q86VQ6 | 2/20 | 0.55 |
| ▸ | TXNRD2 | Q9NNW7 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | GPR35 | Q9HC97 | 5/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | TTR | P02766 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL28272222 | 0.96 | TXNRD1 (0.52) | TXNRD1TXNRD3TXNRD2ALDH1A1GPR35 | |
| SCHEMBL27581734 | 0.80 | ALDH1A1 (0.47) | TXNRD1TXNRD3TXNRD2ALDH1A1GPR35 | |
| SCHEMBL2822069 | 0.77 | ALDH1A1 (0.58) | TXNRD1TXNRD3TXNRD2ALDH1A1GPR35 | |
| SCHEMBL9794431 | 0.77 | VCAM1 (0.47) | TXNRD1TXNRD3TXNRD2ALDH1A1GPR35 | |
| SCHEMBL7297476 | 0.76 | ALDH1A1 (0.43) | TXNRD1TXNRD3TXNRD2ALDH1A1GPR35 | |
| SCHEMBL4076110 | 0.75 | ALDH1A1 (0.56) | TXNRD1TXNRD3TXNRD2ALDH1A1GPR35 | |
| SCHEMBL8686866 | 0.75 | ALDH1A1 (0.56) | TXNRD1TXNRD3TXNRD2ALDH1A1GPR35 | |
| SCHEMBL7348266 | 0.74 | ALDH1A1 (0.50) | TXNRD1TXNRD3TXNRD2ALDH1A1GPR35 | |
| SCHEMBL9761462 | 0.74 | CYP19A1 (0.52) | TXNRD1TXNRD3TXNRD2ALDH1A1GPR35 | |
| Trinitrotoluene SCHEMBL891182 | 0.73 | ALDH1A1 (0.61) | ALDH1A1GPR35TDP1HPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260110607-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES WITH MINIMIZED FALSE POSITIVES | ALTI LLC (US) | 2026-04-23 | — | — | US | claimed |
| US-12517047-B2 | Transport and detection of explosive samples | ALTI LLC (US) | 2026-01-06 | — | — | US | claimed |
| US-20250237601-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES | ALTI LLC | 2025-07-24 | — | — | US | claimed |
| US-20120291931-A1 | COMPOSITE COMPOUND INCLUDING EXPLOSIVE AND MODIFIER FOR EXPLOSIVE AND METHOD OF MANUFACTURE THEREOF | MCDERMOTT WILL & EMERY | 2012-11-22 | — | — | US | claimed |
| US-20100096050-A1 | MODIFIER FOR EXPLOSIVES | LIMITED LIABILITY COMPANY IFO | 2010-04-22 | — | — | US | claimed |
| EP-2128117-A2 | MODIFIER FOR EXPLOSIVES | Obshestvo S Ogranichennoy Otvetstvennjctyu "Ifokhim" (RU) | 2009-12-02 | — | — | EP | claimed |
| CN-1721401-A | Inhibitors of LFA-1 binding to ICAMS and uses thereof | ICOS CORP (US) | 2006-01-18 | — | — | CN | claimed |
| CN-1351588-A | Inhibitor for combination of leukocyte function-associated antigen and intercellular adhesion molecule and application thereof | ICOS CORP (US) | 2002-05-29 | — | — | CN | claimed |
| US-20260110607-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES WITH MINIMIZED FALSE POSITIVES | ALTI LLC (US) | 2026-04-23 | — | — | US | disclosed |
| US-12517047-B2 | Transport and detection of explosive samples | ALTI LLC (US) | 2026-01-06 | — | — | US | disclosed |
| US-20250237601-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES | ALTI LLC | 2025-07-24 | — | — | US | disclosed |
| US-20120291931-A1 | COMPOSITE COMPOUND INCLUDING EXPLOSIVE AND MODIFIER FOR EXPLOSIVE AND METHOD OF MANUFACTURE THEREOF | MCDERMOTT WILL & EMERY | 2012-11-22 | — | — | US | disclosed |
| US-20100096050-A1 | MODIFIER FOR EXPLOSIVES | LIMITED LIABILITY COMPANY IFO | 2010-04-22 | — | — | US | disclosed |
| CN-1721401-A | Inhibitors of LFA-1 binding to ICAMS and uses thereof | ICOS CORP (US) | 2006-01-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260110607-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES WITH MINIMIZED FALSE POSITIVES | TES, TNPO1, SLC2A1 | TXNRD1 673/4885TXNRD3 1430/4885TXNRD2 741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.